Buy Caladrius Biosciences Stock | CLBS Stock Price & Latest News | Public
CLBS

Caladrius Biosciences

$0.00 (0.00%)Today
    Small Market Cap
    View Caladrius Biosciences (CLBS) stock trends here

    About CLBS

    Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes CLBS12, CLBS14, CLBS16, and CLBS03. The company was founded on September 18, 1980 ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.5
    0.24
    -0.03
    -0.29
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.08

    Actual EPS
    Q1 2021

    Stats

    Market Cap$46,35M
    Volume103,7k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.89
    1 Year Low$1.05
    Open$2.32
    High$2.65
    Low$2.32

    Buy any stock with any amount of money.

    Download the App
    Download the app